Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Sight Sciences's peak revenue was $81.1M in 2023. The peak quarterly revenue was $23.5M in 2023(q2).
Sight Sciences's revenue increased from $27.6m in 2020 to $79.9M currently. That's a 188.95% change in annual revenue.
| Fiscal year / year | Sight Sciences revenue |
|---|---|
| 2020 | $27.6M |
| 2021 | $49.0M |
| 2022 | $71.3M |
| 2023 | $81.1M |
| 2024 | $79.9M |
How accurately did Sight Sciences' revenue projections match actual performance?
Sight Sciences saw the greatest revenue growth in 2021, when revenue increased by 77.12%.
Sight Sciences had the lowest revenue growth in 2022, when revenue changed by 45.7%.
| Year | Sight Sciences growth |
|---|---|
| 2021 | 77%↑ |
| 2022 | 46%↑ |
| 2023 | 14%↑ |
| 2024 | -1%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | $12.5M | $13.1M | $14.7M |
| 2022 | $14.9M | $17.2M | $18.7M | $20.5M |
| 2023 | $18.8M | $23.5M | $20.0M | $18.8M |
| 2024 | $19.3M | $21.4M | $20.2M | $19.1M |
Do you work at Sight Sciences?
Did Sight Sciences meet its revenue projections?
| CEO | Paul Badawi |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 147 |
| Date Founded | 2011 |
| Headquarters | Menlo Park, California |
| Number of Locations | 6 |
| Revenue | $79.9M |
| Net Income | -$86,242,000 |
| Gross Proft | $68.3M (2024) |
| Tax Rate | -0.0% |
| Total Assets | $213,073,000 |
| Ticker | SGHT |
Sight Sciences received early financing of $524.0K on 2011-09-12.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $524K | 09/2011 |
| Series A | $6.9M | 10/2015 |
| Series B | $7M | 03/2016 |
| Series C | $10M | 10/2017 |
| Series D | $31M | 09/2019 |
| Series E | $30M | 03/2020 |
| Series Unknown | $23.2M | 12/2020 |
| Investors | Security type |
|---|---|
| Allegro Investment Fund | Series A |
| Scientific Health Development | Series A |
| HICKS EQUITY PARTNERS | Series B |
| Allegro Investment Fund | Series C |
| Kent, Campa and Kate, Inc. - KCK | Series D |
| MidCap Financial | Series D |
| D1 Capital Partners | Series E |
Zippia gives an in-depth look into the details of Sight Sciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sight Sciences. The employee data is based on information from people who have self-reported their past or current employments at Sight Sciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sight Sciences. The data presented on this page does not represent the view of Sight Sciences and its employees or that of Zippia.
Sight Sciences may also be known as or be related to SIGHT SCIENCES, INC., Sight Sciences and Sight Sciences, Inc.